Genetic Analysis AS (XSAT:GEAN.TO.2) EBIT per Share : kr0.00 (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Genetic Analysis AS EBIT per Share?

Genetic Analysis AS's EBIT per Share for the three months ended in Dec. 2023 was kr0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was kr0.00.

During the past 3 years, the average EBIT per Share Growth Rate was 9.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Genetic Analysis AS's EBIT per Share or its related term are showing as below:

XSAT:GEAN.TO.2' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -61.2 Med: -26.1 Max: 9
Current: 9

During the past 5 years, the highest 3-Year average EBIT per Share Growth Rate of Genetic Analysis AS was 9.00% per year. The lowest was -61.20% per year. And the median was -26.10% per year.

XSAT:GEAN.TO.2's 3-Year EBIT Growth Rate is ranked better than
63.43% of 175 companies
in the Medical Diagnostics & Research industry
Industry Median: -1.7 vs XSAT:GEAN.TO.2: 9.00

Genetic Analysis AS's EBIT for the three months ended in Dec. 2023 was kr-6.61 Mil.

Genetic Analysis AS EBIT per Share Historical Data

The historical data trend for Genetic Analysis AS's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetic Analysis AS EBIT per Share Chart

Genetic Analysis AS Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Genetic Analysis AS Quarterly Data
	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EBIT per Share	Get a 7-Day Free Trial										-	-	-	-	-

Genetic Analysis AS EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Genetic Analysis AS's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-23.564	/	0
=	N/A

Genetic Analysis AS's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

	EBIT per Share		(Q: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-6.611	/	0
=	N/A

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00

Genetic Analysis AS (XSAT:GEAN.TO.2) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Genetic Analysis AS EBIT per Share Related Terms

Thank you for viewing the detailed overview of Genetic Analysis AS's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Genetic Analysis AS (XSAT:GEAN.TO.2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetic Analysis AS (XSAT:GEAN.TO.2) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

GEAN:Sweden

Address

Kabelgata 8, Oslo, NOR, 0580

Website

https://www.genetic-analysis.com

Genetic Analysis AS is a research-driven diagnostic company dedicated to delivering innovative diagnostic solutions to the growing human microbiota market. It is providing a CE-marked gut microbiota analysis for testing bacterial imbalance in IBS and IBD patients.

Genetic Analysis AS (XSAT:GEAN.TO.2) Headlines

No Headlines